This page contains the records of free Webinars that Rx-360 has offered previously. These Webinars are source of educational material discussing various topics pertaining to the pharmaceutical supply chain and quality.
Free Webinar: Illegal Diversion of Pharmaceuticals
To Register go to www4.gotomeeting.com/register/412123671
As part of its ongoing educational webinar series designed to further best practices for supply chain security, Rx-360 members will address the topic of illegally diverted pharmaceuticals. Illegal diversion is a nebulous issue with grave consequences: a complex combination requiring well thought-out and proven mitigation strategies. This webinar will contextualize the causes and impact of illegal diversion with case studies specific to this issue. Successful mitigation strategies for illegal diversion within the global pharmaceutical supply chain will be highlighted.
Webinar content is derived from the recently released Illegal Diversion of Pharmaceuticals whitepaper, authored by Rx-360 members from Merck & Co, Amgen, Astra Zeneca, Bristol-Myers Squibb, Genentech, Takeda, Biogen Idec and Johnson & Johnson.
Please click here to register for a free educational webinar on Illegal Diversion of Pharmaceuticals on May 14, 2013
The phenomenon of illegal diversion is driven primarily by arbitrage opportunities created by pricing differentials. Many of these price differences have complex origins that have their foundation in regulations and legislation in particular markets. This paper does not seek to address the subject of pharmaceutical pricing; however, it is important to recognize these price differentials and the role they play in illegal diversion.
Illegal diversion is an issue that can occur within individual markets and between national markets; however, this discussion will focus on illegal diversion that occurs between national markets. This particular risk is rapidly increasing due to the growth of complex and interconnected global commerce. The goal of this paper is to provide a compendium of information regarding illegal diversion: an overview of the supply chain and marketplace vulnerabilities contributing to illegal diversion, the impact of this problem and illegal diversion mitigation strategies that have been successfully deployed by pharmaceutical manufacturers.
To View or Download the Webinar Click on the Slide Below